| 國立成功大學 |
2013-10 |
Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner
|
Cho, Chia-Fong; Chen, Po-Ku; Chang, Po-Chiao; Wu, Hau-Lin; Shi, Guey-Yueh |
| 臺北醫學大學 |
2013 |
Human Platelet Antigen Alleles in 998 Taiwanese Blood donors determined by sequence-specific primer polymerase chain reaction
|
SC, Pai;Burnouf, T;JW, Chen;LI, Lin |
| 臺北醫學大學 |
2013 |
Human Platelet Antigen Alleles in 998 Taiwanese Blood donors determined by sequence-specific primer polymerase chain reaction
|
Pai, SC;Burnouf, T;Chen, JW;Lin, LI |
| 臺北醫學大學 |
2012 |
Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor
|
Burnouf, T;YP, Kuo;Blum, D;Burnouf, S;CY, Su |
| 臺北醫學大學 |
2012 |
Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor
|
Burnouf, T;Kuo, YP;Blum, D;Burnouf, S;Su, CY |
| 臺大學術典藏 |
2022-03-22T08:26:39Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 臺大學術典藏 |
2022-03-22T08:29:32Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 臺大學術典藏 |
2022-03-22T08:29:32Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 國家衛生研究院 |
2021-06-04 |
Human platelet lysate biotherapy for traumatic brain injury: Preclinical assessment
|
Nebie, O;Carvalho, K;Barro, L;Delila, L;Faivre, E;Renn, TY;Chou, ML;Wu, YW;Niem-Redene, A;Chou, SY;Buée, L;Hu, CJ;Peng, CW;Devos, D;Blum, D;Burnouf, T |
| 國立成功大學 |
2022-07 |
Human Platelet Lysate Induces Antiviral Responses against Parechovirus A3
|
Jan;Ming-Wei;Chiu;Chih-Yun;Chen;Jih-Jung;Chang;Tsung-Hsien;Tsai;Kuen-Jer |
| 國家衛生研究院 |
2016-06-11 |
Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement
|
Peng, KY;Lee, YW;Hsu, PJ;Wang, HH;Wang, Y;Liou, JY;Hsu, SH;Wu, KK;Yen, BL |
| 臺大學術典藏 |
2020-03-02T07:41:26Z |
Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement
|
Peng, K.-Y.; Lee, Y.-W.; Hsu, P.-J.; Wang, H.-H.; Wang, Y.; Liou, J.-Y.; Hsu, S.-H.; Wu, K.K.; Yen, B.L.; SHAN-HUI HSU |
| 輔英科技大學 |
2021-01-22 |
Human pluripotent stem cell-derived DDX4 and KRT-8 positive cells participate in ovarian follicle-like structure formation
|
Yu, Danny C.W.;Wu, Fang-Chun;Wu, Chia-Eng;Chow, Lu-Ping;Ho, Hong-Nerng;Chen, Hsin-Fu |
| 臺大學術典藏 |
2021-03-03T02:44:14Z |
Human pluripotent stem cell-derived DDX4 and KRT-8 positive cells participate in ovarian follicle-like structure formation
|
Yu D.C.W.; Wu F.-C.; Wu C.-E.; Chow L.-P.; HONG-NERNG HO; Chen H.-F. |
| 臺大學術典藏 |
2021-10-29T07:40:35Z |
Human pluripotent stem cell-derived DDX4 and KRT-8 positive cells participate in ovarian follicle-like structure formation
|
Yu, Danny C W; Wu, Fang-Chun; Wu, Chia-Eng; LU-PING CHOW; Ho, Hong-Nerng; Chen, Hsin-Fu |
| 臺大學術典藏 |
2018-09-10T09:13:24Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang, H.-P. and Chen, P.-H. and Hwu, W.-L. and Chuang, C.-Y. and Chien, Y.-H. and Stone, L. and Chien, C.-L. and Li, L.-T. and Chiang, S.-C. and Chen, H.-F. and Ho, H.-N. and Chen, C.-H. and Kuo, H.-C.; HSIANG-PO HUANG; HONG-NERNG HO; CHUNG-LIANG CHIEN; YIN-HSIU CHIEN; HSIN-FU CHEN |
| 臺大學術典藏 |
2018-09-10T08:30:46Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang, H.-P. and Chen, P.-H. and Hwu, W.-L. and Chuang, C.-Y. and Chien, Y.-H. and Stone, L. and Chien, C.-L. and Li, L.-T. and Chiang, S.-C. and Chen, H.-F. and Ho, H.-N. and Chen, C.-H. and Kuo, H.-C.; HSIANG-PO HUANG; HONG-NERNG HO; CHUNG-LIANG CHIEN; YIN-HSIU CHIEN; WUH-LIANG HWU; HSIN-FU CHEN |
| 臺大學術典藏 |
2020-02-17T07:43:36Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P; Chen P.-H; Hwu W.-L; Chuang C.-Y; Chien Y.-H; Stone L; Chien C.-L; Li L.-T; Chiang S.-C; Chen H.-F; HONG-NERNG HO; Chen C.-H; Kuo H.-C. |
| 臺大學術典藏 |
2011 |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P; Chen P.-H; Hwu W.-L; Chuang C.-Y; Chien Y.-H; Stone L; Chien C.-L; Li L.-T; Chiang S.-C; Chen H.-F; HONG-NERNG HO; Chen C.-H; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.;Chen P.-H.;Hwu W.-L.;Chuang C.-Y.;Chien Y.-H.;Stone L.;Chung-Liang Chien;Li L.-T.;Chiang S.-C.;Chen H.-F.;Ho H.-N.;Chen C.-H.;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P. ;Chen P.-H. ;Hwu W.-L. ;Chuang C.-Y. ;Chien Y.-H. ;Stone L. ;Chung-Liang Chien ;Li L.-T. ;Chiang S.-C. ;Chen H.-F. ;Ho H.-N. ;Chen C.-H. ;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-12-16T02:25:36Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; WUH-LIANG HWU; Chuang C.-Y.; Chien Y.-H.; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2012 |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; YIN-HSIU CHIEN; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2021-06-03T06:50:17Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
HSIANG-PO HUANG; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-12-24T06:16:52Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; YIN-HSIU CHIEN; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
